New product aims to prevent DVT and PE
A new simple device has been designed to improve venous blood flow of people when seated and to help in the prevention, care and treatment of deep vein thrombosis and pulmonary embolism.
The RBR legﬂow™ was created with the input of Professor Richard Beasley, director of the Medical Research Institute of New Zealand (MRINZ) and a world authority on respiratory medicine who has undertaken ground-breaking research of ‘e-thrombosis’.
He said: “Research from the MRINZ has shown that this device markedly increases lower limb venous blood flow, thereby potentially reducing the risk of blood clots, in people who sit for long periods at work or with long distance air travel.”
As part of its design, the RBR legﬂow™ is manufactured with an antimicrobial ingredient which oﬀers excellent protection against bacteria, bioﬁlm, fungi and mould, and has no adverse eﬀect on the RBR legﬂow™ properties. This antimicrobial element remains eﬀective for the lifetime of the product and all the active components used are approved by the FDA and EPA. The aim is to dramatically reduce the risk of any cross-infection.
Thrombosis key facts:
For more details on this product visit the RBR Active website at https://www.rbractive.com/
READ MORE ARTICLES